It was found that this compound reduced glucose, creatinine kinase, and alkaline phosphatase as well as cholesterol and TAG levels after application to obese, insulin-resistant mice, and mice with hyperinsulinemia [236]. This evidence concerns the gene INS and hyperinsulinism.